Xiaolu Yin
University of Nebraska–Lincoln(US)Shandong University(CN)
Publications by Year
Research Areas
Extraction and Separation Processes, Magnetic properties of thin films, Magnetic Field Sensors Techniques, Fibroblast Growth Factor Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer(2015)290 cited
- → Magnetoresistive Sensor Development Roadmap (Non-Recording Applications)(2019)245 cited
- → Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer(2011)243 cited
- → FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547(2013)237 cited
- → Translating the Therapeutic Potential of AZD4547 in FGFR1 -Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models(2012)155 cited
- → Volitinib, a potent and highly selective c‐Met inhibitor, effectively blocks c‐Met signaling and growth in c‐MET amplified gastric cancer patient‐derived tumor xenograft models(2014)119 cited
- → AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases(2016)96 cited
- → Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non-small cell lung cancer (NSCLC): Updated results from BLOOM, a phase I study.(2016)94 cited
- → High T790M Detection Rate in TKI-Naive NSCLC with EGFR Sensitive Mutation: Truth or Artifact?(2013)82 cited
- → The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere(2013)78 cited